Stay updated on Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.

Latest updates to the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays revision v3.6.3 instead of v3.6.2, indicating a minor update to the site's metadata. It does not alter the main content or capabilities presented to users.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2. This indicates a minor platform or UI/content management update rather than changes to the study data or page functionality.SummaryDifference0.1%

- Check31 days agoChange DetectedEnrollment status now indicates no recruitment; new help/navigation items were added to assist users, and labeling and versioning were updated (Intervention/Treatment vs Intervention / Treatment, Revision: v3.6.0) to reflect the updated page structure.SummaryDifference0.5%

- Check38 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5. This indicates a small metadata update that does not alter the study details or user-facing information.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, reflecting a minor update to the page's revision history. This update does not modify the visible content.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page footer’s software/site revision label is updated from v3.5.2 to v3.5.3, reflecting a backend or display release rather than an update to the ClinicalTrials.gov study information.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.